Mayo researchers find off/on switch for DNA repair protein

July 2, 2018 by Sara Tiner, Mayo Clinic
Researchers clarify the relationship between the repair protein 53BP1, the protein TIRR and RNA molecules released when DNA is damaged. Credit: Mayo Clinic

Damage to DNA is a daily occurrence but one that human cells have evolved to manage. Now, in a new paper published in Nature Structural & Molecular Biology, Mayo researchers have determined how one DNA repair protein gets to the site of DNA damage. The authors say they hope this discovery research will help identify new therapies for ovarian cancer.

While the human genome is constantly damaged, cells have proteins that detect and repair the damage. One of those proteins is called 53BP1. It is involved in the repair of DNA when both strands break. In the publication, Georges Mer, Ph.D., a Mayo Clinic structural biologist, and his team report on how 53BP1 relocates to chromosomes to do its job.

Dr. Mer explains that, in the absence of DNA damage, 53BP1 is inactive—blocked by a called "TIRR." Using a visualization technique called X-ray crystallography, the authors show that TIRR obstructs an area on 53BP1 that 53BP1 uses to bind chromosomes. But what shifts TIRR away from 53BP1, so the repair protein can work?

The authors theorized that a type of nucleic acid called RNA was responsible for this shift. To test their theory, they engineered a protein that would bind to the 53BP1 repair protein and the RNA molecules released when DNA is damaged. This effort, plus other work detailed in the paper, provides evidence that their idea was sound. The authors report that when DNA damage occurs, RNA molecules produced at that time can bind to TIRR, displacing it from 53BP1 and allowing 53BP1 to swing into action.

"Our study provides a proof-of-principle mechanism for how RNA molecules can trigger the localization of 53BP1 to DNA damage sites," says Dr. Mer. "The TIRR/RNA pair can be seen as an off/on switch that blocks or triggers 53BP1 relocation to DNA sites."

Also in the paper, the authors report that displacing TIRR increases sensitivity of cells in cell culture to olaparib, a drug used to treat patients with .

"Unfortunately, over time cancer cells develop resistance to drugs in this category, called 'PARP inhibitors.' Our work provides a new target, TIRR, for developing therapeutics that would help specifically kill ," Dr. Mer says.

Collaborators on this work include the Dana-Farber Cancer Institute and the Wellcome Trust Centre for Human Genetics at the University of Oxford in the U.K. In addition to Dr. Mer, other Mayo Clinic authors are Maria Victoria Botuyan, Ph.D., Gaofeng Cui, Ph.D., James R. Thompson, Ph.D., Benoît Bragantini, Ph.D., and Debiao Zhao, Ph.D.

The authors report no conflict of interest. Funding for this research was provided by the National Institutes of Health, including the Mayo Clinic Ovarian Cancer Specialized Program of Research Excellence, and the U.S. Department of Defense. Additional funding sources are listed in the publication.

Explore further: The fork in the road to DNA repair

More information: Mechanism of 53BP1 activity regulation by RNA-binding TIRR and a designer protein, Nature Structural & Molecular Biology (2018). DOI: 10.1038/s41594-018-0083-z , https://www.nature.com/articles/s41594-018-0083-z

Related Stories

The fork in the road to DNA repair

July 12, 2017

Japanese researchers from Osaka University have uncovered a way in which our cells regulate the repair of broken DNA. Their results, published in the journal Cell Reports show a common molecule regulates multiple repair mechanisms ...

An unexpected player in a cancer defense system

November 28, 2011

Researchers of the Swedish medical university Karolinska Institutet and the University of Cologne, Germany, have identified a new protein involved in a defense mechanism against cancer. The VCP/p97 complex is best known for ...

Cancer treatment potential discovered in gene repair mechanism

December 30, 2014

Case Western Reserve researchers have identified a two-pronged therapeutic approach that shows great potential for weakening and then defeating cancer cells. The team's complex mix of genetic and biochemical experiments unearthed ...

Enzyme helps cancer cells avoid genetic instability

January 21, 2013

Cancer cells are resourceful survivors with plenty of tricks for staying alive. Researchers have uncovered one of these stratagems, showing how cells lacking the tumor suppressor BRCA1 can resume one form of DNA repair, sparing ...

Recommended for you

Decoding the structure of an RNA-based CRISPR system

September 20, 2018

Over the past several years, CRISPR-Cas9 has moved beyond the lab bench and into the public zeitgeist. This gene-editing tool CRISPR-Cas9 holds promise for correcting defects inside individual cells and potentially healing ...

Basking sharks can jump as high and as fast as great whites

September 20, 2018

A collaborative team of marine biologists has discovered that basking sharks, hundreds of which are found off the shores of Ireland, Cornwall, the Isle of Man and Scotland, can jump as fast and as high out of the water as ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.